Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
The kinase NIK as a therapeutic target in multiple myeloma
NIK protein level and activity are controlled by a negative feedback... | Download Scientific Diagram
TAK1 Is Required for Survival of Mouse Fibroblasts Treated with TRAIL, and Does So by NF-κB Dependent Induction of cFLIPL | PLOS ONE
Kinase Selectivity Profiling Systems— STE and TKL
Cells | Free Full-Text | Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes | Journal of Medicinal Chemistry
Kinase inhibition through Ready-to-go cell lines
Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases | Journal of Medicinal Chemistry
Anti-NFkB Inducing Kinase NIK antibody (ab216409) | Abcam
Anti-NFkB Inducing Kinase NIK antibody (ab228587) | Abcam
Frontiers | Interaction of Adipocyte Metabolic and Immune Functions Through TBK1
Ubiquitin Ligases cIAP1 and cIAP2 Limit Cell Death to Prevent Inflammation - ScienceDirect
Unleashing TNF cytotoxicity to enhance cancer immunotherapy: Trends in Immunology
Detecting Kinase Activity Across the Kinome
NIKT3 expression strongly induces the alternative NF-B pathway. (A) NIK... | Download Scientific Diagram
MAP3K kinases and kidney injury | Nefrología
Frontiers | The Therapeutic Potential of Targeting NIK in B Cell Malignancies
IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic
WNK Kinase|Inhibitors Agonists Modulators Antagonists|HmoBio.com
MAP3K kinases and kidney injury - ScienceDirect
TRAF2 Must Bind to Cellular Inhibitors of Apoptosis for Tumor Necrosis Factor (TNF) to Efficiently Activate NF-κB and to Prev
NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis | Cell Death & Differentiation
Small Molecule NF-κB Pathway Inhibitors in Clinic. - Abstract - Europe PMC
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
